Individuals whose current health status is poor will likely derive larger marginal utility benefits from improved health status than persons whose current health status is good or excellent. True False

Consider two treatments. Treatment 1 saves one year of life at a cost of $10,000. Treatment 2 saves ten years of life at a cost of $1,000,000. Which treatment is more cost-effective? Why? Consider two treatments. Treatment 1 saves six years of quality adjusted life at a cost of $90,000. Treatment 2 saves three years of quality adjusted life at a cost of $60,000. Which treatment is preferred from a cost utility analysis perspective? Suppose Jay has been experiencing back pain and that there are two options for back pain: Treatment Regimen  Total Cost Pain Reduction Do nothing $0 0 units Cortisone injections   $600 30 units Calculate the ICER between cortisone injections and doing nothing. Jay says he is willing to pay $10 for a per unit of pain reduction. Should he choose cortisone injections? Another treatment is discovered. It costs $700 and reduces pain by 25 units. Should he choose the new treatment?

Access to health and a person’s health status play an important role in longevity and quality of life.  As we have sadly learned in the pandemic, the majority of serious illnesses and deaths stem from lower income and certain minority groups.  Please discuss your view of these important variables that impact our health system. Please remember to cite at least one source and clearly articulate your views (250 Words)

In the Grossman model, the marginal efficiency of investment in health care declines as health improves. True False

Indicate whether the statement is true or false, and justify your answer.Disproportionate spending on end-of-life care is never clinically justifiable.

Suppose that there are 2 types of plans available to you. Plan A has a deductible of $500, with 10 percent co-insurance rate for many health care services. Plan B has a deductible fo $1000, with 35 percent co-insurance rate. Plan A costs $200 per month in premiums while Plan B costs $80. Discuss characteristics of people who would choose Plan A versus Plan B. Assuming that both plan types exist in the market, who would likely choose Plan B over Plan A? What plan would you choose?

Which of the following hypotheses argues that a third variable, "patient", determines both health and wealth: Fuchs hypothesis efficient producer hypothesis thrifty phenotype hypothesis allostatic load hypothesis access to care hypothesis

"Self-insurance" behaviors are actions one takes that lower the probability of a negative health outcome. (True/False) Economics

Demand for medical services is price inelastic (Absolute value of price elasticity of demand is less than 1 and greater than zero). Medical services are different from most other goods and services in that the person who determines the demand (the patient) is not the person who makes the payment (payment is made by the insurance company). How does this affect the price elasticity of demand for medical services (increase it or decrease it)? You may assume that this question only refers to people who have health insurance. Ignore co-payments and deductibles and any other out-of-pocket expenses. Please give an explanation.

While it may seem intuitively obvious that health expenditures will increase as a population age – older people, after all, are less healthy on average than younger people – in fact, several prominent health economists have argued that it is not ageing per se, but rather some of the correlates of an ageing population that cause health expenditures to rise as population ages. For instance, Getzen (1992) argues that, at least in part, rising health expenditures with an ageing population are due to the higher incomes and resources of the older population; health care is a normal good, so higher incomes lead to higher expenditures. In a similar manner, Zweifel et al. (1999) argue that the real problem with an ageing population, at least as far as health care costs are concerned, is that there will be more people who are within a couple of years of dying. Since health care expenditures rise sharply close to the end of life, it is this, rather than population ageing by itself, that leads to…